Vaccine Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Vaccine Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Cancer Vaccines Immunology
New data from Roswell Park Cancer Institute illuminate research in cancer vaccines immunology
March 19th, 2008
Researchers detail in 'Harnessing the immune system for ovarian cancer therapy,' new data in cancer vaccines. "The clinical course of ovarian cancer is often marked by periods of relapse and remission until chemo-resistance develops. Patients in remission with minimal disease burdens are ideally suited for the evaluation of immune-based strategies," scientists writing in the American Journal of Reproductive Immunology report. "Major obstacles to the development of successful immune strategies include the identification of tumor-restricted immunogenic targets, generation of a sufficient immune response to cause tumor rejection, and approaches to overcome evasion...
Source: Vaccine Weekly (2008-03-19)
|
